These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 702768)
41. Age-dependent modification of drug interference on the enzymatic activities of the rat brain. Benzi G; Arrigoni E; Dagani F; Marzatico F; Curti D; Raimondo S; Dossena M; Polgatti M; Villa RF Exp Gerontol; 1980; 15(6):593-603. PubMed ID: 6258955 [No Abstract] [Full Text] [Related]
42. [Medical treatment of acute disorders of cerebral circulation]. Buscaino GA Acta Neurol Quad (Napoli); 1980; 41():74-81. PubMed ID: 7293741 [No Abstract] [Full Text] [Related]
43. Cyclandelate as a calcium modulating agent in rat cerebral cortex. Bast A; Leurs R; Timmerman H Drugs; 1987; 33 Suppl 2():67-74. PubMed ID: 3040372 [TBL] [Abstract][Full Text] [Related]
44. Effects of vincamine on EEG sleep patterns in man: a pilot study. Albizzati MG; Bassi S; Binda G; Passerini D Curr Med Res Opin; 1980; 6(10):653-7. PubMed ID: 7428402 [TBL] [Abstract][Full Text] [Related]
45. The effect of cyclandelate on cholesterol synthesis. Middleton B; Middleton A; Miciak A; Edwards E; Whitten B; Bell GD; White DA Br J Clin Pract Suppl; 1984; 34():43-50. PubMed ID: 6430323 [No Abstract] [Full Text] [Related]
46. In vivo antispasmodic activity of Sulcotidil. Roba J; Reuse-Blom S; Lambelin G Arch Int Pharmacodyn Ther; 1976 May; 221(1):54-9. PubMed ID: 962430 [TBL] [Abstract][Full Text] [Related]
47. [Effect of vincamine on platelet respiration]. Pesce E; Viganò V; Piacenza G Farmaco Prat; 1978 Aug; 33(8):343-50. PubMed ID: 748059 [No Abstract] [Full Text] [Related]
48. [The effects of vasodilators on the cerebral hemodynanics in the cerebrovascular diseases]. Furuhashi N Nihon Naika Gakkai Zasshi; 1971 Feb; 60(2):89-102. PubMed ID: 4396692 [No Abstract] [Full Text] [Related]
49. [Study of cyclandelate vaso-active properties by the measure of the ear-retina time in the rabbit (author's transl)]. Andermann C; Andermann G; Ehinger C Ann Pharm Fr; 1980; 38(3):253-60. PubMed ID: 7425477 [No Abstract] [Full Text] [Related]
50. Inhibitory action of cyclandelate and a number of its metabolites on cyclic AMP phosphodiesterase. Van den Hoven WE; Hall DW; Burns JW Br J Clin Pract Suppl; 1984; 34():20-5. PubMed ID: 6331483 [No Abstract] [Full Text] [Related]
51. Electronystagmographic study in rabbits on the vestibular effect of vincamine. Hamann KF; Bernhold B; Sattler B; Iatraki L Arzneimittelforschung; 1979; 29(1):34-8. PubMed ID: 312648 [TBL] [Abstract][Full Text] [Related]
52. Drug therapy: cerebral vasodilators (first of two parts). Cook P; James I N Engl J Med; 1981 Dec; 305(25):1508-13. PubMed ID: 7029283 [No Abstract] [Full Text] [Related]
53. [On the influence of vincamine on human cerebral blood flow in the acute test. Studies with 133Xe clearance method (author's transl)]. Kohlmeyer K Arzneimittelforschung; 1977; 27(6a):1285-90. PubMed ID: 578454 [No Abstract] [Full Text] [Related]
54. [The effect of vincamine on vigilance disorders in the elderly (author's transl)]. Moreau J Sem Hop; 1978 Nov 8-15; 54(37-40):1181-4. PubMed ID: 217102 [TBL] [Abstract][Full Text] [Related]
55. Inhibition of aldose reductase from rat nervous tissue by metabolites of cyclandelate. Van den Hoven WE; Hall DW; Burns JW Br J Clin Pract Suppl; 1984; 34():31-3. PubMed ID: 6430320 [No Abstract] [Full Text] [Related]
56. Effect of Vincamine on CBF under pharmacokinetic aspects. Witzmann HK; Siegers CP; Heiss WD; Kohlmeyer K Acta Neurol Scand Suppl; 1977; 64():410-1. PubMed ID: 268853 [No Abstract] [Full Text] [Related]
57. A pilot study to evaluate the effect of acute and long-term administration of cyclandelate on the vigilance of subjects submitted to hypoxic conditions. Preliminary report. Schaffler K; Hörmann E; Arnold H Arzneimittelforschung; 1981; 31(6):1032-5. PubMed ID: 7196236 [TBL] [Abstract][Full Text] [Related]
58. Synthesis and pharmacological evaluation of (nitrooxy)alkyl apovincaminates. Kawashima Y; Ikemoto T; Horiguchi A; Hayashi M; Matsumoto K; Kawarasaki K; Yamazaki R; Okuyama S; Hatayama K J Med Chem; 1993 Apr; 36(7):815-9. PubMed ID: 8464035 [TBL] [Abstract][Full Text] [Related]
59. [Changes in peripheral arterial circulation under the effect of papaverine depending upon the initial condition of patients with coronary insufficiency due to coronary atherosclerosis]. Zubarev VV Ter Arkh; 1972 Sep; 44(9):32-4. PubMed ID: 4660397 [No Abstract] [Full Text] [Related]
60. Studies on the vincamine-papaverine association ii. acute toxicity in experimental animals as a function of the speed of infusion. Nunziata A; Costrini R; Mercatelli P; Perri GC Agressologie; 1978; 19(3):215-9. PubMed ID: 736221 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]